Cocrystal Pharma Inc (COCP) 재무 분석
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|---|
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues | 53.33%0.11 | 0.23 | - | - | - |
27.43%3.29 | 2.58 | 2.48 | 2.09 | 2.11 | |
| Research and Development | 56.24%2.14 | 1.37 | 1.62 | 0.95 | 1.12 |
| Depreciation and Amortization | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 |
| Operating Income/Loss | 35.14%-3.18 | -2.36 | -2.48 | -2.09 | -2.11 |
| Nonoperating Income/Loss | 64.91%0.02 | 0.06 | 0.06 | 0.04 | 0.05 |
| Income Tax Expense/Benefit | - | - | - | - | - |
37.63%-3.16 | -2.30 | -2.43 | -2.05 | -2.06 | |
| Attributable To Parent | 37.63%-3.16 | -2.30 | -2.43 | -2.05 | -2.06 |
| Basic Average Shares | 0.01%13.79 | 13.79 | - | 10.99 | 10.17 |
| Diluted Average Shares | 0.01%13.79 | 13.79 | - | 10.99 | 10.17 |
| Basic Earnings Per Share | 35.29%-0.23 | -0.17 | - | -0.19 | -0.20 |
| Diluted Earnings Per Share | 35.29%-0.23 | -0.17 | - | -0.19 | -0.20 |